Abstract
Azathioprine (AZA) has been given to transplanted patients since 1963 (1), but despite extensive use its metabolism is still not completely understood. After oral administration, it is converted rapidly to 6-mercaptopurine (6MP), mainly in the liver and the gut (2). 6MP is metabolised by three competing pathways (Figure 1): A) conversion to 6-thioinosinic acid by hypoxanthine guanine phosphoribosyltransferase (HPRT) and thence thioguanine nucleotides which exert their cytotoxicity by incorporation into DNA and RNA (2,3); B) catabolism by xanthine oxidase (XOD) to 6-thiouric acid; C) conversion to 6-methyl mercaptopurine (6MeMP) by the enzyme thiopurine methyl transferase (TPMT), which has a wide range of activity in the normal population and is inherited in a autosomal codominant fashion (3,4).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
J.E. Murray, J.P Merrill, J.H. Harrison, R.E. Wilson and G.J. Dammin, Prolonged survival of human-kidney homografts by iramunosuppressive drug therapy. N Engl J Med 268:1315 (1963).
D.M. Tidd and A.R.P. Paterson. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res 34:738 (1974).
R.M. Weinshilboum and S.L. Sladek. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Hum Genet 32:651 (1980).
L. Lennard, J.A. Van Loon and R.M. Weinshilboum. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine raethyltransferase genetic polymorphism. Clin Pharmacol Ther 46:149 (1989).
R.M. Weinshilboum, F.A. Raymond and P.A. Pazmino. Human erythrocyte thiopurine raethyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 85:323 (1978).
C.A. Rees, L. Lennard, J.S. Lilleyman and J.L. Maddocks. Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemia. Cancer Chemother Pharmacol 12:87 (1984).
G.L.C. Chan, G.R. Erdmann, S.A. Gruber, A.J. Matas and D.M. Canafax. Azathioprine metabolism: Pharmacokinetics of 6-mercaptopurine, 6-thiouric and 6-thioguanine nucleotides in renal transplant patients. J Clin Pharmacol 30: 358 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chocair, P.R., Duley, J.A., Simmonds, H.A., Cameron, J.S. (1991). Thiopurine Methyltransferase Activity and Efficacy of Azathioprine Immunosuppression in Transplant Recipients. In: Harkness, R.A., Elion, G.B., Zöllner, N. (eds) Purine and Pyrimidine Metabolism in Man VII. Advances in Experimental Medicine and Biology, vol 309A. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2638-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2638-8_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2640-1
Online ISBN: 978-1-4899-2638-8
eBook Packages: Springer Book Archive